Cargando…
Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculation: A systematic review and Bayesian network meta-analysis
BACKGROUND: We performed the network meta-analysis (NMA) and systematic review involved all evidence from relevant trials to compare the efficiency and safety of various types of selective serotonin reuptake inhibitors (SSRI) and phosphodiesterase-5 inhibitors (PDE5i) in patients with premature ejac...
Autores principales: | Jin, Kun, Deng, Linghui, Qiu, Shi, Tu, Xiang, Li, Jiakun, Bao, Yige, Yang, Lu, Wei, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310608/ https://www.ncbi.nlm.nih.gov/pubmed/30544399 http://dx.doi.org/10.1097/MD.0000000000013342 |
Ejemplares similares
-
Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation
por: Simsek, Abdulmuttalip, et al.
Publicado: (2014) -
Genetic polymorphism in the serotonin transporter gene-linked polymorphic region and response to serotonin reuptake inhibitors in patients with premature ejaculation
por: Ozbek, Emin, et al.
Publicado: (2014) -
Hypothalamic‐related neural mechanism in lifelong premature ejaculation and trends following selective serotonin reuptake inhibitor administration
por: Geng, Bowen, et al.
Publicado: (2022) -
Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
por: Shin, Dongseong, et al.
Publicado: (2017) -
Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial
por: Siroosbakht, Soheila, et al.
Publicado: (2019)